All Stories

Breaking down pharma’s fourth-quarter sales boom

This week on "The Top Line," we dissect the unprecedented revenue growth enjoyed by many major pharma companies in 2024’s fourth quarter.

Mar 14, 2025 - 14:11
 0
Breaking down pharma’s fourth-quarter sales boom
This week on "The Top Line," we dissect the unprecedented revenue growth enjoyed by many major pharma companies in 2024’s fourth quarter.
Read More

Tags:

Previous Article

ETIHAD MAKES FLIGHTS TO MEDAN, INDONESIA AVAILABLE TO BOOK NOW

Next Article

“There’s an appetite for not what’s already there” – Brother’s Bond on global op...

Related Posts

Regulatory tracker: FDA starts new review of Regeneron's bispecific antibody odronextamab

Regulatory tracker: FDA starts new review of Regeneron'...

Feb 27, 2025  0

AstraZeneca pays $160M for Fibrogen's China unit, regional rights to roxadustat

AstraZeneca pays $160M for Fibrogen's China unit, regio...

Feb 20, 2025  0

After $2.2B Zantac settlement, GSK now faces investor lawsuit over the heartburn medication

After $2.2B Zantac settlement, GSK now faces investor l...

Feb 9, 2025  0